STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

PKTX amends Form 8-K to revise press release and contact info

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
8-K/A

Rhea-AI Filing Summary

ProtoKinetix, Incorporated (PKTX) filed an amended Form 8-K to update a prior current report. The Amendment corrects the Company’s contact telephone number and attaches a revised version of a press release that was posted on the Company’s website on November 17, 2025.

The updated press release is furnished as Exhibit 99.1 under Regulation FD Disclosure and is not treated as filed for liability purposes or incorporated by reference into other securities law filings. No financial results, business strategy, or transactional details are changed by this Amendment.

Positive

  • None.

Negative

  • None.
true The sole purpose of this Amendment is to correct the contact number for the Company included in the Original Filing and include a revised copy of the press release posted on the Company's website on November 17, 2025. 0001128189 0001128189 2025-11-13 2025-11-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K/A

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report: November 13, 2025

 

ProtoKinetix, Incorporated

(Exact name of registrant as specified in its charter)

         
Nevada   000-32917   94-3355026

State of Incorporation

 

Commission

File Number

 

IRS Employer

Identification Number

 

109 W Main Street,

Dalton, OH 44618

Address of principal executive offices

 

330-445-4971

Telephone number, including Area Code

 

_______________________________

 

 Former name or former address if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
N/A        

 

 

 
 

 

 

Item 7.01. Regulation FD Disclosure.

 

This Current Report on Form 8-K/A (this “Amendment”) amends that certain Current Report on Form 8-K filed by ProtoKinetix, Incorporated (the “Company”) with the Securities and Exchange Commission on November 17, 2025 (the “Original Filing”). The sole purpose of this Amendment is to correct the contact number for the Company included in the Original Filing and include a revised copy of the press release posted on the Company’s website on November 17, 2025. The full text of the press release referenced herein is furnished hereto as Exhibit 99.1 and incorporated herein by reference.

 

The information in this Item 7.01 of the Form 8-K, including Exhibit 99.1, is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

 

Item 9.01. Financial Statements and Exhibits.

 

  Exhibit
No.
  Description
  99.1  

Press release dated November 17, 2025

  104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

  

 

 

 
 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on the 19th day of November 2025.

  

ProtoKinetix, Inc.  
     
By:   /s/ Michael Guzzetta  
  

Michael Guzzetta, President, CEO & CFO

 

 

 

 

 

 

FAQ

What is ProtoKinetix (PKTX) reporting in this Form 8-K/A?

ProtoKinetix is filing an amendment to a prior Form 8-K solely to correct its contact telephone number and to include a revised press release as Exhibit 99.1.

Does this PKTX 8-K/A include new financial or operating results?

No new financial results or operating data are described. The Amendment only updates contact information and furnishes a revised press release.

What is contained in Exhibit 99.1 to the ProtoKinetix 8-K/A?

Exhibit 99.1 is a press release dated November 17, 2025, which has been revised from the version referenced in the Original Filing and is incorporated by reference in the current report.

Is the ProtoKinetix press release in this 8-K/A considered filed with the SEC?

The press release in Exhibit 99.1 is furnished under Item 7.01 and is expressly stated as not deemed “filed” for purposes of Section 18 of the Exchange Act or incorporated by reference into Securities Act filings.

Does this amendment change any of ProtoKinetix’s previously disclosed transactions or strategies?

The Amendment states that its sole purpose is to correct the Company’s contact number and provide a revised press release; it does not alter previously disclosed transactions or strategic information.

Who signed the ProtoKinetix 8-K/A amendment?

The Amendment was signed on behalf of ProtoKinetix by Michael Guzzetta, President, CEO & CFO.
Protokinetix Inc

OTC:PKTX

PKTX Rankings

PKTX Latest News

PKTX Latest SEC Filings

PKTX Stock Data

2.65M
244.03M
37.92%
0.01%
Biotechnology
Healthcare
Link
United States
Dalton